These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26075072)

  • 1. Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients.
    Guo C; Pei QI; Tan H; Huang Z; Yuan H; Yang G
    Biomed Rep; 2015 Mar; 3(2):195-200. PubMed ID: 26075072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation
.
    Huang Y; Wen G; Lu Y; Wen J; Ji Y; Xing X; Li Y; Wen J; Yuan H
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):109-118. PubMed ID: 27841150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects.
    Han JM; Yee J; Chung JE; Lee KE; Park K; Gwak HS
    Mol Genet Genomic Med; 2020 May; 8(5):e1201. PubMed ID: 32134573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysis.
    Zuo XC; Zhang WL; Yuan H; Barrett JS; Hua Y; Huang ZJ; Zhou HH; Pei Q; Guo CX; Wang JL; Yang GP
    Drug Metab Pharmacokinet; 2014; 29(4):305-11. PubMed ID: 24522199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy.
    Cai J; Huang Z; Yang G; Cheng K; Ye Q; Ming Y; Zuo X; Zhou P; Yuan H
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):401-9. PubMed ID: 22149319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CYP3A4*1G, CYP3A5*3, POR*28, and ABCB1 C3435T on the pharmacokinetics of nifedipine in healthy Chinese volunteers.
    Wang XF; Yan L; Cao HM; Wei LM; Yang WH; Zhang SJ; Zhang LR
    Int J Clin Pharmacol Ther; 2015 Sep; 53(9):737-45. PubMed ID: 26104034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.
    Kim KA; Park PW; Lee OJ; Choi SH; Min BH; Shin KH; Chun BG; Shin JG; Park JY
    Clin Pharmacol Ther; 2006 Dec; 80(6):646-56. PubMed ID: 17178265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication.
    Karaca RO; Kalkisim S; Altinbas A; Kilincalp S; Yuksel I; Goktas MT; Yasar U; Bozkurt A; Babaoglu MO
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):199-206. PubMed ID: 27611887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics and pharmacodynamics of amlodipine in hypertensive patients with and without type II diabetes mellitus.
    Preston RA; Chung M; Gaffney M; Alonso A; Baltodano NM; Epstein M
    J Clin Pharmacol; 2001 Nov; 41(11):1215-24. PubMed ID: 11697754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients.
    Berno G; Zaccarelli M; Gori C; Tempestilli M; Pucci L; Antinori A; Perno CF; Pucillo LP; D'Arrigo R
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19589. PubMed ID: 25394094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of
    Chan SW; Chu TTW; Ho CS; Kong APS; Tomlinson B; Zeng W
    Front Med (Lausanne); 2021; 8():683498. PubMed ID: 34568359
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of CYP3A4*1G and CYP3A5*3 polymorphisms on pharmacokinetics of tylerdipine hydrochloride in healthy Chinese subjects.
    Zhou S; Tao M; Wang Y; Wang L; Xie L; Chen J; Zhao Y; Liu Y; Zhang H; Ou N; Wang G; Shao F; Aa J
    Xenobiotica; 2019 Mar; 49(3):375-380. PubMed ID: 29521134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cytochrome P450 3A5*3 genotype on the stereoselective pharmacokinetics of amlodipine in healthy subjects.
    Kim KA; Park PW; Park JY
    Chirality; 2009 May; 21(5):485-91. PubMed ID: 18752284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.
    Zhang JJ; Liu SB; Xue L; Ding XL; Zhang H; Miao LY
    Int J Clin Pharmacol Ther; 2015 Sep; 53(9):728-36. PubMed ID: 26227094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of genetic polymorphisms of CYP2C19*2/*3 and MDR1 C3435T on the pharmacokinetics of lansoprazole in healthy Chinese subjects.
    Zhang YX; Wei SJ; Yang XY; Zhang WP; Wang XY; Dang HW
    Int J Clin Pharmacol Ther; 2014 Oct; 52(10):850-5. PubMed ID: 25109411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of
    Liang H; Zhang X; Ma Z; Sun Y; Shu C; Zhu Y; Zhang Y; Hu S; Fu X; Liu L
    Pharmgenomics Pers Med; 2021; 14():189-197. PubMed ID: 33564260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administration.
    Fredericks S; Holt DW; MacPhee IA
    Am J Pharmacogenomics; 2003; 3(5):291-301. PubMed ID: 14575518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats.
    Wang R; Zhang H; Sun S; Wang Y; Chai Y; Yuan Y
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):825-833. PubMed ID: 26650374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention.
    Park KW; Kang J; Park JJ; Yang HM; Lee HY; Kang HJ; Koo BK; Oh BH; Park YB; Kim HS
    Heart; 2012 Sep; 98(18):1366-72. PubMed ID: 22735685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.